DISEASE INDICATIONS: Rheumatoid Arthritis
MANUFACTURER: Galapagos
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Jyseleca is a medication with the generic name filgotinib. It is a Janus kinase (JAK) inhibitor used in the treatment of certain autoimmune and inflammatory conditions, primarily rheumatoid arthritis.